Interventional antimicrobial therapy of febrile complications after high dose therapy and autologous stem cell transplantation;Interventionelle antimikrobielle therapie febriler komplikationen nach hochdosistherapie und autologer stammzelltransplantation

Deutsche Medizinische Wochenschrift

Volumn 124, Issue SUPPL. 1, 1999, Pages

  Maschmeyer, Georg ^a   Hertenstein, Bernd ^b   Glaß, Bertram ^c   Schiel, Xaver ^d  

^a Section of Pathology   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC THERAPY; AUTOTRANSPLANTATION; DRUG CHOICE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; SHORT SURVEY;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFECTION; NEOPLASMS; RISK; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032919538     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. American Society of Clinical Oncology: American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J. Clin. Oncol. 12(1994), 2471-2508.
2. American Society of Clinical Oncology: Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J. Clin. Oncol. 14 (1996), 1957-1960.
3. Ayash, L. J., A. Elias, C. Wheeler, E. Reich, G. Schwartz, R. Mazanet, I. Tepler, D. Warren, C. Lynch, R. Gonin, L. Schnipper, E. Frei III, K. Antman: Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. J. Clin. Oncol. 12(1994), 37-44.
4. Ayash, L. J., A. Elias, G. Schwartz, C. Wheeler, C. Ibrahim, B. A. Teicher, E. Reich, D. Warren, C. Lynch, P. Richardson, L. Schnipper, E. Frei III, K. Antman: Double dose intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. J. Clin. Oncol. 14(1996), 2984-2992.
5. Bitran, J. D., B. Samuels, L. Klein, S. Hanauer, L. Johnson, J. Martinec, E. Harris, J. Kempler, W. White: Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. Bone Marrow Transplant 17 (1996), 157-162.
6. Cornely O. A., W. Hiddemann, H. Link, G. Maschmeyer, B. Glass, D. Buchheidt, M. Wilhelm, T. H. Büchner, T. H. Lipp, R. Haas, V. Heinemann, M. Helmerking, D. Adam for the Study Group of the PEG: Interventional antimicrobial therapy in febrile neutropenic patients - Paul Ehrlich Society for Chemotherapy (PEG) study II. Ann. Hematol. 74(1997), Suppl. 1:A51.
7. Dompeling, E. C., J. P. Donnelly, S. C. Derensinski, R. Feld, E. F. Lane-Allman, B. E. de Pauw: Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin. Europ. J. Cancer 32 A(1996), 1332-1339.
8. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trial Group: Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patient. J. Infect. Dis. 163 (1991), 951-958.
9. Gilbert, C., B. Meisenberg, J. Vredenburgh, M. Ross, A. Hussein, J. Perfect, W. P. Peters: Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. J. Clin. Oncol. 12(1994), 1005-1011.
10. Glenn, J., D. Cotton, R. Wesley, P. Pizzo: Anorectal infections in patients with malignant diseases. Rev. Infect. Dis. 10(1988), 42-52.
11. Holland, H. K., S. P. Dix, R. B. Geller, S. M. Devine, L. T. Heffner, D. G. Connaghan, C. D. Hillyer, L. L. Hughes, R. L. Müller, M. R. Moore, E. F. Winton, J. R. Wingard: Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care. J. Clin. Oncol. 14(1996), 1156-1164.
12. Hughes, W. T., D. Armstrong, G. P. Bode, R. Feld, G. L. Mandell, J. D. Meyers, P. A. Pizzo, S. C. Schimpff, J. L. Shenep, J. C. Wade, L. S. Young, M. D. Yow: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J. Infect. Dis. 161 (1990), 381-396.
13. Hughes, W.., P. A. Pizzo, J. C. Wade, D. Armstrong, C. D. Webb, L. S. Young: Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 15(1992), Suppl. 1:S206-S215.
14. Hughes W. T., D. Armstrong, G. P. Bodey, A. E. Brown, J. E. Edwards, R. Feld, P. Pizzo, K. V. I. Rolston, J. L. Sheep, L. S. Young: 1997guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin. Infect. Dis. 25(1997), 551-573.
15. Immunocompromised Host Society Consensus Panel (Pizzo, P. A., D. Armstrong, G. Bodey, B. de Pauw, R. Feld, M. Glauser, H. Gaya, J. Karp, J.Klastersky, G. Todeschini, J. Verhoef, J. Wade, L. S. Young, J. Remington): The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient: report of a consensus panel for the Immunocompromised Host Society. J. Infect. Dis. 161 (1990), 397-401.
16. Kolbe, K., D. Domkin, H. G. Derigs, S. Bhakdi, C. Huber, W. E. Aulitzky: Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant. 19(1996), 143-147.
17. Krüger, W. H., C. Salomon, B. Rüssmann, M. Stockschläder, J. Grimm, N. Kröger, M. Dewit, P. Bieling, M. Horstmann,W. Fiedler, H. Kabisch, R. Erttmann, A. R. Zander: Early infections in bone marrow and blood stem cell transplantation. Bone Marrow Transplant. 19(1997) Suppl. 1:S166.
18. Larrea, L., I. Jarque, J. de la Rubia, L. Belloch, M. Arnao, J. Cervera, P. Solves, A. Sempere, C. Jiménez, G., Sanz, G. Martin, J. Martínez, M. A. Sanz: Early infections after autologous blood stem cell transplantation: a study of 145 patients. Bone Marrow Transplant. 19 (1997) Suppl. 1:S166
19. Link, H., W. Hiddemann, G. Maschmeyer, D. Buchheidt, B. Glass, O. Cornely, M. Wilhelm, M. Helmerking, D. Adam and the PEG Study Group: Antimicrobial therapy in neutropenic patients with unexplained fever, PEG Study II. Proc. Intersc. Conf. Antimicrob. Agents Chemother. 37 (1997), 372.
20. Mahendra, P., S. K. Jacobson, S. Ager, G. Bass, P. Barker, D. Johnson, T. P. Baglin, R. E. Marcus: Short-course intravenous antibiotics with oral quinolone prophylaxis in the treatment of neutropenic fever in autologous bone marrow or peripheral blood progenitor cell transplant recipients. Acta Haematol. 96(1996), 64-67.
21. Meisenberg, B. R., W. E. Miller, R. McMillan, M. Callaghan, C. Sloan, T. Brehm, M. P. Kosty, J. Kroener, R. Longmire, A. Saven, L. D. Piro: Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. J. Clin. Oncol. 15(1997), 11-17.
22. Mossad, S. B., D. L. Longworth, M. Goormastic, J. M. Serkey, T. F. Keys, B. J. Bolwell: Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant. 18(1996), 265-271.
23. Nosanchuk, J. D., K. A. Sepkowitz, R. N. Pearse, M. H. White, S. D. Nimer, D. Armstrong: Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant. 18 (1996), 355-359.
24. Peters, W. P., M. Ross, J. J. Vredenburgh, B. Meisenberg, L. B. Marks, E. Winer, J. Kurtzberg, R. C. Bast Jr., R. Jones, E. Shpall, K. Wu, G. Rosner, C. Gilbert, B. Mathias, D. Coniglio, W. Petros, I. C. Henderson, L. Norton, R. B. Weiss, D. Budman, D. Hurd: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J. Clin. Oncol. 11(1993), 1132-1143.
25. Rolston, K. V., G. P. Bodey: Diagnosis and management of perianal and perirectal infection in the granulocytopenic patient. Curr. Clin. Top. Infect. Dis. 13(1993), 164-171.
26. Rolston, K. V., N. Dholakia, S. Rodriguez, E. B. Rubenstein: Nature and outcome of febrile episodes in patients with pancreatic and hepatobiliary cancer. Support Care Cancer 3(1995), 414-417.
27. Salutari, S., S. Sica, S., L. Laurenti, F. Leone, P. Chiusolo, N. Piccirillo, G. Micciulli, G. Leone: Incidence of sepsis after peripheral blood progenitor cell transplantation: analysis of 86 consecutive hemato-oncological patients. Leuk. Lymphoma 30(1998), 193-197.
28. Sola, C., P. Maroto, R. Salazar, J. M. Tabernero, G. Huidobro, M. Bellet, V. Valenti, M. C. Alonso, A. López Pousa, G. Verger, J. J. López López: Analysis of infectious events during high-dose chemotherapy and peripheral blood stem cell autologous transplantation. Proc. Am. Soc. Clin. Oncol. 15(1996), 539.
29. Verweij, P. E., J. P. Donnelly, B. J. Kullberg, J. F. G. M. Meis, B. E. de Pauw: Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients. Infection 22(1994), 81-85.
30. Weaver, C. H., L. S. Schwartzberg, J. Hainsworth, F. A. Greco, W. Li, C. D. Buckner, W. H. West: Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplant. 19(1997), 671-678.